Real-world Patient Reported Outcomes Among Patients Treated With Camzyos

A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy

NCT05582395 ·Status: COMPLETED ·Phase: PHASE3

The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction

NCT07103655 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy

NCT04349072 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy

NCT06253221 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER

NCT03496168 ·Status: COMPLETED ·Phase: PHASE2

Real-World Effectiveness of Mavacamten in Canada

NCT06338202 ·Status: COMPLETED

COLLIGO-HCM: A Multinational Observational Study of the Real-World Effectiveness of Mavacamten Among Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

NCT06372457 ·Status: ACTIVE_NOT_RECRUITING

Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy

NCT01150461 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

NCT03442764 ·Status: COMPLETED ·Phase: PHASE2

A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)

NCT07004972 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy

NCT03470545 ·Status: COMPLETED ·Phase: PHASE3

A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy

NCT05414175 ·Status: COMPLETED ·Phase: PHASE3

Positron Emission Tomography to Assess the Effect of Camzyos on Ischaemia in HOCM: PEACH Trial

NCT07120776 ·Status: RECRUITING ·Phase: NA

Efficacy of Mavacamten in Patients With Symptomatic Latent Obstructive Hypertrophic Cardiomyopathy

NCT06947590 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Study Evaluating The Effect of Bosutinib (SKI-606) On Cardiac Repolarization (Rhythms Of The Heart)

NCT00914121 ·Status: COMPLETED ·Phase: PHASE1

Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy

NCT04164732 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction

NCT02842242 ·Status: COMPLETED ·Phase: PHASE2

Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other Causalities

NCT04572893 ·Status: TERMINATED ·Phase: PHASE2

Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy

NCT06393465 ·Status: COMPLETED

A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

NCT07210723 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy

NCT06516068 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

NCT03759392 ·Status: COMPLETED ·Phase: PHASE3

Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy

NCT02291237 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Evaluate the Efficacy of Disopyramide Therapy in Hypertrophic Obstructive Cardiomyopathy Patients

NCT02917395 ·Status: UNKNOWN ·Phase: NA

Comparison of Squat-to-Stand Maneuver With Amyl Nitrite, Valsalva, and Exercise Stress Echocardiography in Inducing Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy

NCT04905173 ·Status: WITHDRAWN ·Phase: NA